Moleculin Biotech shareholders approve warrant share issuance, reject name change to Moleculin Inc.

Moleculin Biotech, Inc.

Approved issuance of up to 2,610,823 shares upon exercise of warrants issued Dec 11, 2025; 578,385 For, 68,176 Against.
Name change amendment from Moleculin Biotech, Inc. to Moleculin Inc. failed: 1,124,921 For (needed >1,346,766 majority of outstanding shares).
Adjournment proposal approved (582,534 For, 64,190 Against) to allow further proxy solicitation if needed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.